Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?

Nugent EK, Bishop EA, Mathews CA, Moxley KM, Tenney M, Mannel RS, Walker JL, Moore KN, Landrum LM, McMeekin DS.

Gynecol Oncol. 2012 Apr;125(1):94-8. doi: 10.1016/j.ygyno.2011.11.049. Epub 2011 Dec 7.

PMID:
22155415
2.

[Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Jun;46(6):435-40. Chinese.

PMID:
21781585
3.

Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.

Chee JJ, Ho TH, Tay EH, Low JJ, Yam KL.

Ann Acad Med Singapore. 2003 Sep;32(5):670-5.

PMID:
14626800
4.

Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer?

Kwon JS, Qiu F, Saskin R, Carey MS.

Obstet Gynecol. 2009 Oct;114(4):736-43. doi: 10.1097/AOG.0b013e3181b96ec6.

PMID:
19888029
5.

Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.

Boren T, Lea J, Kehoe S, Miller DS, Richardson D.

Gynecol Oncol. 2012 Oct;127(1):43-6. doi: 10.1016/j.ygyno.2012.06.018. Epub 2012 Jun 16.

PMID:
22713294
6.

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

Guntupalli SR, Zighelboim I, Kizer NT, Zhang Q, Powell MA, Thaker PH, Goodfellow PJ, Mutch DG.

Gynecol Oncol. 2012 Jan;124(1):31-5. doi: 10.1016/j.ygyno.2011.09.017. Epub 2011 Oct 26.

7.

[Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Mu T, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):33-9. Chinese.

PMID:
22455691
8.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.

Anticancer Res. 2000 May-Jun;20(3B):1977-84.

PMID:
10928137
9.

Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.

Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S.

J Obstet Gynaecol Res. 2010 Oct;36(5):1044-8.

PMID:
21058438
10.

Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.

Schwab KV, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE.

Gynecol Oncol. 2009 Jan;112(1):146-9. doi: 10.1016/j.ygyno.2008.09.009. Epub 2008 Oct 19.

PMID:
18937970
11.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
12.
13.

[Multivariate analysis of prognostic factors in endometrial carcinoma].

Li B, Wu LY, Li SM, Zhang WH, Zhang R, Ma SK.

Ai Zheng. 2004 Sep;23(9):1085-8. Chinese.

PMID:
15363208
14.

[Clinical implications of positive peritoneal cytology in endometrial cancer].

Ren YL, Wang HY, Shan BE, Ping B, Shi DR.

Zhonghua Fu Chan Ke Za Zhi. 2011 Aug;46(8):595-9. Chinese.

PMID:
22169518
15.
16.

[Synchronous primary cancers of the endometrium and ovary: review of 43 cases].

Ma SK, Zhang HT, Sun YC, Wu LY.

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):690-4. Chinese.

PMID:
19173912
17.

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.

Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G.

Arch Gynecol Obstet. 2006 May;274(2):91-6. Epub 2006 Mar 4.

PMID:
16518607
18.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
19.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
20.

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.

Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS.

Cancer. 2006 Oct 15;107(8):1823-30.

Supplemental Content

Support Center